<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36310225</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1940-6029</ISSN><JournalIssue CitedMedium="Internet"><Volume>2551</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Methods in molecular biology (Clifton, N.J.)</Title><ISOAbbreviation>Methods Mol Biol</ISOAbbreviation></Journal><ArticleTitle>Neuronal Puncta/Aggregate Formation by WT and Mutant UBQLN2.</ArticleTitle><Pagination><StartPage>561</StartPage><EndPage>573</EndPage><MedlinePgn>561-573</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/978-1-0716-2597-2_34</ELocationID><Abstract><AbstractText>Protein aggregates are a common feature of nearly all neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS). Here we describe a method to quickly and accurately measure protein aggregation in cells expressing a fluorescently tagged aggregation-prone protein. This unbiased method obviates the need for manual scoring and facilitates the identification of factors governing protein self-assembly and its downstream consequences for cell heath.</AbstractText><CopyrightInformation>&#xa9; 2023. Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Safren</LastName><ForeName>Nathaniel</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan Health System, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharkey</LastName><ForeName>Lisa M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan Health System, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barmada</LastName><ForeName>Sami J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan Health System, Ann Arbor, MI, USA. sbarmada@umich.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AG072931</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS097542</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS113943</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Methods Mol Biol</MedlineTA><NlmUniqueID>9214969</NlmUniqueID><ISSNLinking>1064-3745</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D066329">Protein Aggregates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C405662">UBQLN2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071183">Autophagy-Related Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066329" MajorTopicYN="N">Protein Aggregates</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071183" MajorTopicYN="N">Autophagy-Related Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D048868" MajorTopicYN="N">Adaptor Proteins, Signal Transducing</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Longitudinal microscopy</Keyword><Keyword MajorTopicYN="N">Neurodegeneration</Keyword><Keyword MajorTopicYN="N">Protein aggregation</Keyword><Keyword MajorTopicYN="N">Proteostasis</Keyword><Keyword MajorTopicYN="N">Single cell</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>31</Day><Hour>0</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36310225</ArticleId><ArticleId IdType="mid">NIHMS1929498</ArticleId><ArticleId IdType="pmc">PMC10519613</ArticleId><ArticleId IdType="doi">10.1007/978-1-0716-2597-2_34</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Deng H-X, Chen W, Hong S-T et al. (2011) Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature 477(7363):211&#x2013;215. 10.1038/nature10353</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10353</ArticleId><ArticleId IdType="pmc">PMC3169705</ArticleId><ArticleId IdType="pubmed">21857683</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams KL, Warraich ST, Yang S et al. (2012) UBQLN2/ubiquilin 2 mutation and pathology in familial amyotrophic lateral sclerosis. Neurobiol Aging 33(10):2527.e3&#x2013;2527.e10. 10.1016/j.neurobiolaging.2012.05.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.05.008</ArticleId><ArticleId IdType="pubmed">22717235</ArticleId></ArticleIdList></Reference><Reference><Citation>Teyssou E, Chartier L, Amador MDM et al. (2017) Novel UBQLN2 mutations linked to amyotrophic lateral sclerosis and atypical hereditary spastic paraplegia phenotype through defective HSP70-mediated proteolysis. Neurobiol Aging 58:239.e11&#x2013;239.e20. 10.1016/j.neurobiolaging.2017.06.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.06.018</ArticleId><ArticleId IdType="pubmed">28716533</ArticleId></ArticleIdList></Reference><Reference><Citation>Gkazi SA, Troakes C, Topp S et al. (2019) Striking phenotypic variation in a family with the P506S uBqLN2 mutation including amyotrophic lateral sclerosis, spastic paraplegia, and frontotemporal dementia. Neurobiol Aging 73:229.e5&#x2013;229.e9. 10.1016/j.neurobiolaging.2018.08.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.08.015</ArticleId><ArticleId IdType="pubmed">30348461</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Van Deerlin VM, Robinson JL et al. (2012) Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion. Acta Neuropathol 123(6):825&#x2013;839. 10.1007/s00401-012-0970-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-0970-z</ArticleId><ArticleId IdType="pmc">PMC3521561</ArticleId><ArticleId IdType="pubmed">22426854</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori F, Tanji K, Odagiri S et al. (2012) Ubiquilin immunoreactivity in cytoplasmic and nuclear inclusions in synucleinopathies, polyglutamine diseases and intranuclear inclusion body disease. Acta Neuropathol 124(1): 149&#x2013;151. 10.1007/s00401-012-0999-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-0999-z</ArticleId><ArticleId IdType="pubmed">22661321</ArticleId></ArticleIdList></Reference><Reference><Citation>Safren N, Chang L, Dziki KM et al. (2015) Signature changes in ubiquilin expression in the R6/2 mouse model of Huntington&#x2019;s disease. Brain Res 1597:37&#x2013;46. 10.1016/j.brainres.2014.12.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2014.12.008</ArticleId><ArticleId IdType="pmc">PMC4340744</ArticleId><ArticleId IdType="pubmed">25511991</ArticleId></ArticleIdList></Reference><Reference><Citation>Dao TP, Kolaitis RM, Kim HJ et al. (2018) Ubiquitin modulates liquid-liquid phase separation of UBQLN2 via disruption of multivalent interactions. Mol Cell 69(6):965&#x2013;978.e6. 10.1016/j.molcel.2018.02.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.02.004</ArticleId><ArticleId IdType="pmc">PMC6181577</ArticleId><ArticleId IdType="pubmed">29526694</ArticleId></ArticleIdList></Reference><Reference><Citation>Dao TP, Martyniak B, Canning AJ et al. (2019) ALS-linked mutations affect UBQLN2 Oligomerization and phase separation in a position- and amino acid-dependent manner. Structure 27(6):937&#x2013;951. 10.1016/J.STR.2019.03.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.STR.2019.03.012</ArticleId><ArticleId IdType="pmc">PMC6551275</ArticleId><ArticleId IdType="pubmed">30982635</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Jones HB, Dao T et al. (2019) Single amino acid substitutions in stickers, but not spacers, substantially alter UBQLN2 phase transitions and dense phase material properties. J Phys Chem B 123(17):3618&#x2013;3629. 10.1021/acs.jpcb.9b01024</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jpcb.9b01024</ArticleId><ArticleId IdType="pubmed">30925840</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharkey LM, Safren N, Pithadia AS et al. (2018) Mutant UBQLN2 promotes toxicity by modulating intrinsic self-assembly. Proc Natl Acad Sci U S A 115(44):E10495&#x2013;E10504. 10.1073/pnas.1810522115</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1810522115</ArticleId><ArticleId IdType="pmc">PMC6217421</ArticleId><ArticleId IdType="pubmed">30333186</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins N, Lin B, Monteiro MJ (2019) Lou Gehrig&#x2019;s disease (ALS): UBQLN2 mutations strike out of phase. Structure 27(6):879&#x2013;881. 10.1016/j.str.2019.05.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2019.05.006</ArticleId><ArticleId IdType="pmc">PMC7267892</ArticleId><ArticleId IdType="pubmed">31167121</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Nirujogi RS, Myong S et al. (2018) Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation. Proc Natl Acad Sci U S A 115(49):E11485&#x2013;E11494. 10.1073/pnas.1811997115</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1811997115</ArticleId><ArticleId IdType="pmc">PMC6298105</ArticleId><ArticleId IdType="pubmed">30442662</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramdzan YM, Polling S, Chia CPZ et al. (2012) Tracking protein aggregation and mislocalization in cells with flow cytometry. Nat Methods 9(5):467&#x2013;470. 10.1038/nmeth.1930</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.1930</ArticleId><ArticleId IdType="pubmed">22426490</ArticleId></ArticleIdList></Reference><Reference><Citation>Weskamp K, Safren N, Miguez R et al. (2019) Monitoring neuronal survival via longitudinal fluorescence microscopy. J Vis Exp 143. 10.3791/59036</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/59036</ArticleId><ArticleId IdType="pmc">PMC6594158</ArticleId><ArticleId IdType="pubmed">30735193</ArticleId></ArticleIdList></Reference><Reference><Citation>Viesselmann C, Ballweg J, Lumbard D et al. (2010) Nucleofection and primary culture of embryonic mouse hippocampal and cortical neurons. J Vis Exp 47. 10.3791/2373</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/2373</ArticleId><ArticleId IdType="pmc">PMC3182630</ArticleId><ArticleId IdType="pubmed">21304471</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacifici M, Peruzzi F (2012) Isolation and culture of rat embryonic neural cells: a quick protocol. J Vis Exp 63. 10.3791/3965</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/3965</ArticleId><ArticleId IdType="pmc">PMC3466945</ArticleId><ArticleId IdType="pubmed">22664838</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>